Chick-fil-A Inc., an American restaurant chain specializing in chicken sandwiches, announced it will no longer serve chicken that is antibiotic-free. This decision reversed the brand's long-time pledge of "No Antibiotics Ever."
Why Chick-fil-A Changed Its Stance
According to Associated Press News, Chick-fil-A's move was prompted by the predicted supply shortage. This is also a sudden change of heart from its vow not to use chicken fed with antibiotics.
For years, Chick-fil-A has committed to serving only antibiotic-free chickens. The chain explained that this pledge is intended to help prevent human antibiotic resistance related to the widespread use of the drugs in most livestock production.
A Shift to Standard NAIHM
The restaurant announced it would now embrace a standard called the "no antibiotics important to human medicine" (NAIHM), which means it would allow some antibiotics. The NAIHM involves steering clear of certain medications that are commonly used for the treatment of humans and restricting the usage of animal antibiotics to particular instances of animal illness.
Chick-fil-A shared that it will apply the new NAIHM policy starting this spring. Through its spokesperson, the company said this move mirrors its concerns about its capability to obtain enough supplies of antibiotic-free chicken.
"To maintain supply of the high-quality chicken you expect from us, Chick-fil-A will shift from No Antibiotics Ever (NAE) to No Antibiotics Important To Human Medicine (NAIHM) starting in the Spring of 2024," Chick-fil-A said in a statement.
The fast-food chain added, "NAE means no antibiotics of any kind were used in raising the animal. NAIHM restricts the use of those antibiotics that are important to human medicine and commonly used to treat people, and allows the use of animal antibiotics only if the animal and those around it were to become sick."
Photo by: Malhar Patel/Unsplash


NTSB Leads Investigation Into Ryanair Boeing 737 Engine Failure Over Greece
Netflix Stock Drops After Weak Q3 Outlook Overshadows Mixed Q2 Earnings
Airbus Signs Cloud Deal With Scaleway to Power Secure AI and Defense Applications
Stripe, Advent Offer Over $53 Billion to Acquire PayPal in Major Fintech Deal
Sodexo Unveils Shift & Grow 2030 Strategy, Targets Over 5% Revenue Growth by Fiscal 2030
Jamie Dimon Warns Anthropic's Mythos AI Poses National Security Risks
SpaceX Eyes Pentagon AI Deal as Cloud Pricing Strategy Pressures CoreWeave
SpaceX Aborts Starship Test Flight as Engine Issue Delays Launch
NY Times Challenges Trump Administration Subpoenas Over Air Force One Report
Apple Intelligence Cleared for China as Alibaba and Baidu AI Power iPhone Features
GameStop Raises eBay Stake to 9.8% as Ryan Cohen Pushes $56 Billion Takeover Bid
Seven & i Eyes Żabka Stake in Major European Expansion Push
United Airlines Beats Q2 Earnings, Raises 2026 Profit Outlook Despite Higher Fuel Costs
Sam Altman Admits OpenAI Missteps, Promises Major AI Comeback Focused on User Freedom
PayPal Rejects $53 Billion Stripe-Advent Takeover Offer as Too Low: Report
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
BHP Q4 Iron Ore Output Rebounds as Copper Prices Boost Revenue 



